That’s just silly – not tomention incorrect re your calc and shares on issue.
You cannot just look atshares on issue and rev to derive market value – that’s 101 stuff and clearlyjust suiting your well established negative agenda. My statement is based on:
MXC’s market cap in comparisonto competitors within MM on ASX and other bio pharma co’s
Price to Rev growth calc (PEGratio for the nerds)
Historical performance of thestock (ie when you claim to have happily traded it above 10 cents it had farless rev and therefor far less…)
Increased commercialisation pipeline+ other potentially price sensitive near term drivers such as first MM co tolist of LSE, derma re brand + yu shop
That’s just silly – not tomention incorrect re your calc and...
Add RGT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
28.0¢ |
Change
-0.005(1.75%) |
Mkt cap ! $13.55M | |||
| Open | High | Low | Value | Volume |
| 28.5¢ | 28.5¢ | 28.0¢ | $913 | 3.258K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 11127 | 28.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 28.5¢ | 49929 | 1 |
View Market Depth
| Last trade - 10.07am 29/07/2024 (20 minute delay) ? |
| RGT (ASX) Chart |